A detailed history of Quarry LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Quarry LP holds 6,500 shares of ARWR stock, worth $132,340. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,500
Previous 8,500 23.53%
Holding current value
$132,340
Previous $221 Million 43.01%
% of portfolio
0.03%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.36 - $29.54 $38,720 - $59,080
-2,000 Reduced 23.53%
6,500 $126 Million
Q2 2024

Aug 14, 2024

BUY
$21.87 - $28.24 $65,610 - $84,720
3,000 Added 54.55%
8,500 $221 Million
Q1 2024

May 15, 2024

BUY
$27.21 - $39.48 $84,351 - $122,387
3,100 Added 129.17%
5,500 $157 Million
Q4 2023

Feb 14, 2024

SELL
$21.2 - $31.03 $54,166 - $79,281
-2,555 Reduced 51.56%
2,400 $73.4 Million
Q3 2023

Nov 14, 2023

BUY
$26.2 - $36.08 $129,821 - $178,776
4,955 New
4,955 $133 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.16B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.